TickerFacts.

A business in context

ARWR research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-18 · 0001250379-26-000002

  2. 4 · Ownership change

    Report date 2026-08-18 · 0001242615-26-000002

  3. 8-K · Current report

    Report date 2026-08-04 · 0000879407-26-000058 · Items 2.02,9.01

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0000879407-26-000057

  5. 4 · Ownership change

    Report date 2026-06-15 · 0002141314-26-000004

  6. 8-K · Current report

    Report date 2026-06-12 · 0000879407-26-000050 · Items 5.02,9.01

  7. 4 · Ownership change

    Report date 2026-05-12 · 0001767584-26-000002

  8. 10-Q · Quarterly report

    Report date 2026-03-31 · 0000879407-26-000047

  9. 8-K · Current report

    Report date 2026-05-07 · 0000879407-26-000045 · Items 2.02,9.01

  10. 4 · Ownership change

    Report date 2026-04-23 · 0001830755-26-000007

  11. 4 · Ownership change

    Report date 2026-04-22 · 0000879407-26-000039

  12. 8-K · Current report

    Report date 2026-03-19 · 0000879407-26-000037 · Items 5.07,9.01

  13. 4 · Ownership change

    Report date 2026-03-05 · 0001830755-26-000006

  14. 10-Q · Quarterly report

    Report date 2025-12-31 · 0000879407-26-000034

  15. 8-K · Current report

    Report date 2026-02-05 · 0000879407-26-000033 · Items 2.02,9.01

  16. DEF 14A · Proxy statement

    Report date 2026-01-26 · 0000879407-26-000019

  17. 8-K · Current report

    Report date 2026-01-12 · 0001193125-26-010582 · Items 1.01,2.03,9.01

  18. 8-K · Current report

    Report date 2026-01-07 · 0001193125-26-007971 · Items 1.01,8.01,9.01

  19. 4 · Ownership change

    Report date 2026-01-06 · 0002081169-26-000002

  20. 8-K · Current report

    Report date 2026-01-06 · 0000879407-26-000004 · Items 7.01,8.01,9.01

  21. 10-K · Annual report

    Report date 2025-09-30 · 0000879407-25-000029

  22. 8-K · Current report

    Report date 2025-11-25 · 0000879407-25-000027 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2025-11-18 · 0000879407-25-000019 · Items 8.01,9.01

  24. 10-K/A · Annual report

    Report date 2024-09-30 · 0000879407-25-000013

  25. 8-K · Current report

    Report date 2025-09-11 · 0000879407-25-000010 · Items 8.01,9.01

  26. 8-K · Current report

    Report date 2025-09-10 · 0000879407-25-000007 · Items 8.01,9.01

  27. 8-K · Current report

    Report date 2025-09-02 · 0000879407-25-000004 · Items 1.01,9.01

  28. 8-K · Current report

    Report date 2025-08-07 · 0001628280-25-038867 · Items 2.02,9.01

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001628280-25-038858

  30. 8-K · Current report

    Report date 2025-05-12 · 0001628280-25-024675 · Items 2.02,9.01

  31. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001628280-25-024666

  32. 8-K · Current report

    Report date 2025-04-11 · 0001628280-25-017844 · Items 5.02

  33. 8-K · Current report

    Report date 2025-03-12 · 0001628280-25-013619 · Items 5.07,9.01

  34. 8-K · Current report

    Report date 2025-02-10 · 0001628280-25-004637 · Items 2.02,9.01

  35. 10-Q · Quarterly report

    Report date 2024-12-31 · 0001628280-25-004634

  36. 8-K · Current report

    Report date 2025-02-07 · 0001628280-25-004313 · Items 5.02,9.01

  37. DEF 14A · Proxy statement

    Report date 2025-01-28 · 0001628280-25-002848

  38. 8-K · Current report

    Report date 2024-12-11 · 0001628280-24-051729 · Items 5.02,9.01

  39. 8-K · Current report

    Report date 2024-11-26 · 0001628280-24-049281 · Items 2.02,9.01

  40. 10-K · Annual report

    Report date 2024-09-30 · 0001628280-24-049277

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 5 transaction rows5SGrant / award: 1 transaction rows1AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

6 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-15
2026-06-17
Cohen Matthew GregoryA · Grant / award
Acquired
Common Stock11882.00.0
2026-05-12
2026-05-14
Lu Hongbo
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2970.076.88
2026-04-23
2026-04-24
Hamilton James C
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock10000.075.0
2026-04-22
2026-04-24
Apel Daniel Joseph
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8730.071.92
2026-04-22
2026-04-24
Apel Daniel Joseph
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1157.070.45
2026-04-22
2026-04-24
Apel Daniel Joseph
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3208.070.11

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000879407ARROWHEAD PHARMACEUTICALS, INC.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300O3CSB8T7OZ3D66
GLEIF legal name
Arrowhead Pharmaceuticals, Inc.
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-02-24T06:14:37Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Arrowhead Pharmaceuticals · alias · wikidata
  • ARROWHEAD RESEARCH CORP · former SEC name · 2004-01-13 to 2016-04-06
  • INTERACTIVE GROUP INC · former SEC name · 2002-05-13 to 2004-01-09
  • INTERACTIVE INC · former SEC name · 1998-01-02 to 2002-02-13
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2025-09-30$829.45M$865.54M
2024-09-30$3.55M$3.81M
2023-09-30$240.74M$265.92M
2022-09-30$243.23M$282.28M
2021-09-30$138.29M$173.19M
2020-09-30$87.99M$113.88M
2019-09-30$168.80M$221.57M
2018-09-30$16.14M$21.58M

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗